Record Information |
---|
Version | 2.0 |
---|
Created at | 2023-03-17 17:20:50 UTC |
---|
Updated at | 2024-09-03 04:16:04 UTC |
---|
NP-MRD ID | NP0331537 |
---|
Natural Product DOI | https://doi.org/10.57994/0513 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Eriocalyxin K |
---|
Description | Speciociliatine belongs to the class of organic compounds known as corynanthean-type alkaloids. These are alkaloids with a structure based on the corynanthean nucleus, which is a tetracycle characterized by an indole fused to a quinolizidine. Additionally, the quinolizidine ring system is substituted to a 2-methylpropyl group and one ethyl group. Eriocalyxin K was first documented in 2020 (PMID: 32597657). Based on a literature review a significant number of articles have been published on Speciociliatine (PMID: 33620222) (PMID: 35472200) (PMID: 35468648) (PMID: 33408731) (PMID: 35335999) (PMID: 34803709). |
---|
Structure | CC[C@@H]1CN2CCC3=C(NC4=CC=CC(OC)=C34)[C@H]2C[C@@H]1\C(=C/OC)C(=O)OC InChI=1S/C23H30N2O4/c1-5-14-12-25-10-9-15-21-18(7-6-8-20(21)28-3)24-22(15)19(25)11-16(14)17(13-27-2)23(26)29-4/h6-8,13-14,16,19,24H,5,9-12H2,1-4H3/b17-13+/t14-,16+,19-/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C22H30O8 |
---|
Average Mass | 422.4740 Da |
---|
Monoisotopic Mass | 422.19407 Da |
---|
IUPAC Name | methyl (2E)-2-[(2S,3S,12bR)-3-ethyl-8-methoxy-1H,2H,3H,4H,6H,7H,12H,12bH-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate |
---|
Traditional Name | methyl (2E)-2-[(2S,3S,12bR)-3-ethyl-8-methoxy-1H,2H,3H,4H,6H,7H,12H,12bH-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@@]12C[C@]3(C(=O)[C@H]1C)C(=O)OC[C@@]14CC[C@H](OC(C)=O)[C@@](C)(CO)[C@@]1([H])C(O)O[C@H](C2)[C@]34[H] |
---|
InChI Identifier | InChI=1S/C22H30O8/c1-10-12-6-13-15-21(9-28-19(27)22(15,7-12)17(10)25)5-4-14(29-11(2)24)20(3,8-23)16(21)18(26)30-13/h10,12-16,18,23,26H,4-9H2,1-3H3/t10-,12+,13+,14-,15-,16+,18?,20+,21+,22-/m0/s1 |
---|
InChI Key | PYFIJXXKLSSPNC-NVIRHUQUSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 300.11, C5D5deposition_typeN, simulated) | Not Available | Not Available | Not Available | 2024-05-11 | View Spectrum |
| Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
eriocalyx | | |
|
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as corynanthean-type alkaloids. These are alkaloids with a structure based on the corynanthean nucleus, which is a tetracycle characterized by an indole fused to a quinolizidine. Additionally, the quinolizidine ring system is substituted to a 2-methylpropyl group and one ethyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Corynanthean-type alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Corynanthean-type alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Corynanthean skeleton
- Beta-carboline
- Pyridoindole
- Quinolizine
- 3-alkylindole
- Indole
- Indole or derivatives
- Anisole
- Phenol ether
- Alkyl aryl ether
- Aralkylamine
- Benzenoid
- Piperidine
- Heteroaromatic compound
- Vinylogous ester
- Alpha,beta-unsaturated carboxylic ester
- Pyrrole
- Enoate ester
- Methyl ester
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid ester
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Organoheterocyclic compound
- Azacycle
- Ether
- Organic oxygen compound
- Organic nitrogen compound
- Organonitrogen compound
- Carbonyl group
- Amine
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Kamble SH, Berthold EC, King TI, Raju Kanumuri SR, Popa R, Herting JR, Leon F, Sharma A, McMahon LR, Avery BA, McCurdy CR: Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats. J Nat Prod. 2021 Apr 23;84(4):1104-1112. doi: 10.1021/acs.jnatprod.0c01163. Epub 2021 Feb 23. [PubMed:33620222 ]
- Flores-Bocanegra L, Raja HA, Graf TN, Augustinovic M, Wallace ED, Hematian S, Kellogg JJ, Todd DA, Cech NB, Oberlies NH: The Chemistry of Kratom [Mitragyna speciosa]: Updated Characterization Data and Methods to Elucidate Indole and Oxindole Alkaloids. J Nat Prod. 2020 Jul 24;83(7):2165-2177. doi: 10.1021/acs.jnatprod.0c00257. Epub 2020 Jun 29. [PubMed:32597657 ]
- Zhang M, Sharma A, Leon F, Avery B, Kjelgren R, McCurdy CR, Pearson BJ: Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance. PLoS One. 2022 Apr 26;17(4):e0259326. doi: 10.1371/journal.pone.0259326. eCollection 2022. [PubMed:35472200 ]
- Manwill PK, Flores-Bocanegra L, Khin M, Raja HA, Cech NB, Oberlies NH, Todd DA: Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products. Planta Med. 2022 Apr 25. doi: 10.1055/a-1795-5876. [PubMed:35468648 ]
- Zhang M, Sharma A, Leon F, Avery B, Kjelgren R, McCurdy CR, Pearson BJ: Effects of Nutrient Fertility on Growth and Alkaloidal Content in Mitragyna speciosa (Kratom). Front Plant Sci. 2020 Dec 21;11:597696. doi: 10.3389/fpls.2020.597696. eCollection 2020. [PubMed:33408731 ]
- Tanna RS, Nguyen JT, Hadi DL, Manwill PK, Flores-Bocanegra L, Layton ME, White JR, Cech NB, Oberlies NH, Rettie AE, Thummel KE, Paine MF: Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants. Pharmaceutics. 2022 Mar 11;14(3). pii: pharmaceutics14030620. doi: 10.3390/pharmaceutics14030620. [PubMed:35335999 ]
- Gutridge AM, Chakraborty S, Varga BR, Rhoda ES, French AR, Blaine AT, Royer QH, Cui H, Yuan J, Cassell RJ, Szabo M, Majumdar S, van Rijn RM: Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder. Front Pharmacol. 2021 Nov 3;12:764885. doi: 10.3389/fphar.2021.764885. eCollection 2021. [PubMed:34803709 ]
- Hughs M, Kish-Trier E, O'Brien A, McMillin GA: Analysis of Mitragynine and Speciociliatine in Umbilical Cord by LC-MS/MS for Detecting Prenatal Exposure to Kratom. J Anal Toxicol. 2022 Sep 1. pii: 6680066. doi: 10.1093/jat/bkac064. [PubMed:36047661 ]
- Karunakaran T, Ngew KZ, Zailan AAD, Mian Jong VY, Abu Bakar MH: The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review. Front Pharmacol. 2022 Feb 24;13:805986. doi: 10.3389/fphar.2022.805986. eCollection 2022. [PubMed:35281925 ]
- Domnic G, Jeng-Yeou Chear N, Abdul Rahman SF, Ramanathan S, Lo KW, Singh D, Mohana-Kumaran N: Combinations of indole based alkaloids from Mitragyna speciosa (Kratom) and cisplatin inhibit cell proliferation and migration of nasopharyngeal carcinoma cell lines. J Ethnopharmacol. 2021 Oct 28;279:114391. doi: 10.1016/j.jep.2021.114391. Epub 2021 Jul 2. [PubMed:34224811 ]
- Berthold EC, Kamble SH, Raju KS, King TI, Popa R, Sharma A, Leon F, Avery BA, McMahon LR, McCurdy CR: Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS/MS method. J Pharm Biomed Anal. 2021 Feb 5;194:113778. doi: 10.1016/j.jpba.2020.113778. Epub 2020 Nov 21. [PubMed:33277117 ]
- Kamble SH, Berthold EC, Kanumuri SRR, King TI, Kuntz MA, Leon F, Mottinelli M, McMahon LR, McCurdy CR, Sharma A: Metabolism of Speciociliatine, an Overlooked Kratom Alkaloid for its Potential Pharmacological Effects. AAPS J. 2022 Jul 19;24(5):86. doi: 10.1208/s12248-022-00736-8. [PubMed:35854066 ]
- Damodaran T, Chear NJ, Murugaiyah V, Mordi MN, Ramanathan S: Comparative Toxicity Assessment of Kratom Decoction, Mitragynine and Speciociliatine Versus Morphine on Zebrafish (Danio rerio) Embryos. Front Pharmacol. 2021 Aug 20;12:714918. doi: 10.3389/fphar.2021.714918. eCollection 2021. [PubMed:34489704 ]
- Lee MJ, Ramanathan S, Mansor SM, Tan SC: Development of an ELISA for detection of mitragynine and its metabolites in human urine. Anal Biochem. 2020 Jun 15;599:113733. doi: 10.1016/j.ab.2020.113733. Epub 2020 Apr 14. [PubMed:32302607 ]
- Basiliere S, Kerrigan S: Identification of metabolites and potential biomarkers of kratom in urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Mar 1;1140:121971. doi: 10.1016/j.jchromb.2020.121971. Epub 2020 Jan 11. [PubMed:32058315 ]
- Mu L, Li T, Wu PL, Cai LQ, Li SY, Wang ZY, Liu YY, Wang J, Yan D, Rao ZY, Wang CJ, Zhang J, Cao Y, Pan K, Yin ZQ: 5-epi-ent-Kaurane diterpenoids from the aerial parts of Isodon eriocalyx and their anti-atherosclerotic potential. Phytochemistry. 2023 May;209:113621. doi: 10.1016/j.phytochem.2023.113621. Epub 2023 Mar 7. [PubMed:36893826 ]
|
---|